Skip to content
EveryOption

Obsessive-Compulsive Disorder care options

We show care options we have checked for this need. We may not have all options. This page cannot tell you which is best for you.

Published Sep 21, 2026Revision 4 · EveryOptionEnglish (United States)

Published treatment options

These are the options we have published. This order does not say which is best for you.

4 published options

Assessment for Obsessive-Compulsive Disorder

Not reviewed means no current published assessment for the exact pair. No published conclusion means an assessment exists without a research conclusion. Neither establishes benefit or no benefit.

Compare published options

Exposure and response prevention therapy (ERP) for Obsessive-Compulsive Disorder

This assessment belongs to this exact Treatment and Need. It does not extend its conclusion to other populations or formats.

Research suggests benefit in this exact scope

Published Oct 7, 2026 · revision 4

What research says

NICE CG31, recommendation 1.5.1.1, identifies psychological treatment that includes ERP as a low-intensity initial option for adults with OCD when impairment in everyday functioning is mild, when they prefer a low-intensity approach, or both. This is an attributed guideline recommendation for that adult group.

Official guideline documents · checked Oct 3, 2026

Relationship: supports the attributed adult initial-treatment recommendation and its delivery qualifiers

Statement scope

Formulation or format

brief individual cognitive behavioural therapy (CBT; including ERP) using structured self‑help materials; brief individual CBT (including ERP) by telephone; group CBT (including ERP)

Guideline

CG31

Indication

obsessive-compulsive disorder

Intensity

up to 10 therapist hours per patient; group CBT (including ERP) may exceed 10 hours

Treatment phase

initial treatment

Population

Adults with OCD whose functional impairment is mild and/or who prefer a low-intensity approach

Recommendation

1.5.1.1

Source collection coverage: global

Pointer: /document/recommendation

Open source

Delivery and time commitment

For this initial-treatment pathway, NICE CG31 describes low-intensity care as using up to 10 hours of therapist time per patient. Its listed formats include brief individual CBT with ERP supported by structured self-help materials, brief individual CBT with ERP by telephone, and group CBT with ERP. In the group format, a patient may receive more than 10 hours of therapy.

Official guideline documents · checked Oct 3, 2026

Relationship: supports the attributed adult initial-treatment recommendation and its delivery qualifiers

Statement scope

Formulation or format

brief individual cognitive behavioural therapy (CBT; including ERP) using structured self‑help materials; brief individual CBT (including ERP) by telephone; group CBT (including ERP)

Guideline

CG31

Indication

obsessive-compulsive disorder

Intensity

up to 10 therapist hours per patient; group CBT (including ERP) may exceed 10 hours

Treatment phase

initial treatment

Population

Adults with OCD whose functional impairment is mild and/or who prefer a low-intensity approach

Recommendation

1.5.1.1

Source collection coverage: global

Pointer: /document/recommendation

Open source

More intensive option

For adults with OCD whose day-to-day functioning is moderately impaired, England’s NICE guideline CG31 (recommendation 1.5.1.3) says they should be offered a choice between a course of an SSRI medicine and more intensive CBT that includes ERP, meaning more than 10 hours of therapist time, because the two appear to be comparably effective. This describes a guideline pathway; a local provider’s approach and an individual’s needs may differ.

Official guideline documents · checked Oct 7, 2026

Relationship: supports the attributed moderate-impairment choice and intensive therapist time

Statement scope

Alternative

a course of an SSRI

Delivery

more intensive CBT (including ERP; more than 10 therapist hours per patient)

Guideline

CG31

Indication

Obsessive-compulsive disorder

Population

Adults with OCD with moderate functional impairment covered by NICE CG31

Recommendation

1.5.1.3

Section

1.5.1 Initial treatment options: Adults

Source collection coverage: global

Pointer: /document/recommendation

Open source

Severe impairment option

For adults with OCD whose day-to-day functioning is severely impaired, England’s NICE guideline CG31 (recommendation 1.5.1.4) says they should be offered combined treatment: an SSRI medicine together with CBT that includes ERP. This describes a guideline pathway; a local provider’s approach and an individual’s needs may differ.

Official guideline documents · checked Oct 7, 2026

Relationship: supports the attributed severe-impairment combined treatment

Statement scope

Delivery

combined treatment with an SSRI and CBT (including ERP)

Guideline

CG31

Indication

OCD

Population

Adults with OCD with severe functional impairment

Recommendation

1.5.1.4

Section

1.5.1 Initial treatment options: Adults

Source collection coverage: global

Pointer: /document/recommendation

Open source

Children and young people

For children and young people with OCD whose functioning is moderately to severely impaired, or mildly impaired when guided self-help has not worked or was declined, NICE CG31 (recommendation 1.5.1.9) names CBT that includes ERP as the treatment of choice, involving the family or carers and adapted to the child’s developmental age. This describes a guideline pathway in England; a local provider’s approach and an individual’s needs may differ.

Official guideline documents · checked Oct 7, 2026

Relationship: supports the attributed young-people treatment of choice and its family and age adaptations

Statement scope

Delivery

CBT (including ERP) that involves the family or carers and is adapted to suit the developmental age of the child

Format

Group or individual formats depending upon the preference of the child or young person and their family or carers

Guideline

CG31

Indication

OCD

Issuer

National Institute for Health and Care Excellence

Population

Children and young people with OCD with moderate to severe functional impairment, and those with OCD with mild functional impairment for whom guided self-help has been ineffective or refused

Recommendation

1.5.1.9

Section

1.5.1 Initial treatment options: Children and young people

Source collection coverage: global

Pointer: /document/recommendation

Open source
Read the exact scope and sources

Summary

Obsessive-compulsive disorder (OCD) is a treatment-navigation Need; options shown here are scoped to the evidence and access records retained by EveryOption.

Official guideline documents · checked Aug 24, 2026

Relationship: supports

Statement scope

Document

CG31

Jurisdiction

United Kingdom

Population

adults with OCD

Source collection coverage: global

Pointer: /document/recommendation

Access

These are the options and access paths EveryOption has published for Denver for Obsessive-Compulsive Disorder. This is not complete coverage of the condition or the city.

Provider-owned websites · checked Sep 21, 2026

Relationship: supports Denver access navigation

Statement scope

Geography

Denver, Colorado, United States

Need

Obsessive-Compulsive Disorder

Treatment

Exposure and response prevention therapy (ERP)

Source collection coverage: global

Pointer: /page/capability

Open source

Find care

Open the published Denver result for this Need and treatment. It is one sourced path, not complete coverage or a statement of current availability.

Find Exposure and response prevention therapy (ERP) in Denver

You can also look for documented medication evaluation or ongoing management for Obsessive-Compulsive Disorder, without selecting a specific medication.

Find medication services

Ways this Need may be described

Source-backed language helps people find this Need without creating a diagnosis or storing a health profile.

Diagnosis
Trastorno obsesivo-compulsivo
WHO ICD-11 · checked Aug 30, 2026

Relationship: nombre fuente

Statement scope

Applicability details are not published for this statement.

Source collection coverage: global

Pointer: /code

Open source

Published relationship sources

These sources explain why each Treatment is listed for this Need. They are separate from its exact-pair assessment.

Exposure and response prevention therapy (ERP) for Obsessive-Compulsive Disorder

GuíaSalud GPC 634: TOC en niños y adolescentes · checked Oct 16, 2026

Relationship: recomendado para población pediátrica con TOC

Statement scope

Jurisdiction

Sistema Nacional de Salud de España

Population

niños y adolescentes con TOC

Source collection coverage: country:ES

Pointer: /recommendations/0

Open source
Official guideline documents · checked Aug 24, 2026

Relationship: guideline recommendation

Statement scope

Document

CG31

Jurisdiction

United Kingdom

Population

adults with OCD

Source collection coverage: global

Pointer: /document/recommendation

CLOMIPRAMINE HYDROCHLORIDE for Obsessive-Compulsive Disorder

DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026

Relationship: labeled indication

Statement scope

Formulation or format

capsule

Indication

treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)

Labeler

SpecGx LLC

Population

patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age

Product

ANAFRANIL (clomipramine hydrochloride) capsule

Section code

34067-9

Source collection coverage: country:US

Pointer: /sections/0

Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Open source

Fluoxetine for Obsessive-Compulsive Disorder

DailyMed fluoxetine hydrochloride label · checked Oct 16, 2026

Relationship: labeled indication

Statement scope

Formulation or format

tablets (product labeled Fluoxetine Hydrochloride capsule; Indications and Usage text refers to Fluoxetine Tablets; 60-mg scored tablet dosage form)

Indication

Obsessive Compulsive Disorder (OCD)

Population

adults and pediatric patients 7 to 17 years of age with Obsessive Compulsive Disorder (OCD), as labeled

Section code

34067-9

Source collection coverage: country:US

Pointer: /sections/1

Open source

Sertraline for Obsessive-Compulsive Disorder

DailyMed sertraline (Zoloft) label · checked Oct 16, 2026

Relationship: labeled indication

Statement scope

Formulation or format

tablet, film coated; oral solution

Indication

obsessive-compulsive disorder

Population

patients with obsessive-compulsive disorder as labeled

Section code

34067-9

Source collection coverage: country:US

Pointer: /sections/1

Open source

See something wrong? Tell us. Your note is private. We check sources before we change this page.